相关实验视频

Updated: Aug 1, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.8K

索拉费尼布在治疗中期肝细胞癌患者的疗效,这些患者不耐跨动脉化学栓塞治疗

Reham Ashour1, Eman Rewisha1, Mohamed Akl Rady1

  • 1Department of Hepatology and Gastroenterology, National Liver Institute, Menoufia University, Shibin El-Kom, 32511, Egypt.

BMC cancer
|November 28, 2024
PubMed
概括

转换为索拉费尼布显著改善了中期肝细胞癌 (HCC) 耐穿动脉化学栓塞 (TACE) 耐药的患者的结果. 这为管理TACE不再有效的疾病进展提供了更好的替代方案.

关键词:
肝细胞癌是肝细胞癌.在中期阶段的患者中.它们的折射性.索拉费尼布 (Sorafenib) 是一种通过动脉化学栓塞的超动脉化疗.

更多相关视频

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

5.5K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

385

相关概念视频

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...